1 2 3 4 5 6 7
читать далее ... 2005, 196 6. Pincus Т, Yazici Y, Sokka Т, et al. Methotrexate as the «anchor drug» for the treatment of валу arthritis. Clin Exp. Rheumatol 2003; 21: (SuppI 31): 8179-185^, 7. Pincus T, Sokka Т, Kautiainen H. Patients seen for standart rheumatoid arthritis care have significant better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005; 52: 109-1019. 8. Olsen NJ, Stein M. New drugs for rheumatoid arthritis. New EngI J Med 2004; 240; 2176-2179 9. Насонов Е.Л, Чичасова Н.В. Чижова К.А. Перспективы применения лефлуномида в ревматологии. РМЖ 2004; 20: 1147-1151 10. Насонов Е.Л., Каратеев Д.Е., Чичасова Н.В. Новые возможности применения лефлуномида при ревматоидном артрите - ранняя и комбинированная терапия. РМЖ 2005; 13 (24): 1573-1576 11. Grigor С, Cappell H, McMacon AD, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 2004; 364: 263-269 12. Combe В, Landewe R, Lukas G, et al. EUIAR recommendations for the management of early arthritis: report of task force of the European Standing Committee for International Studies Including Therapeutics (ESCISIT). Ann Rheum Dis; online 5 Jan 2006. 13. Ревматология. Клинические рекомендации. Под редакцией Е.Л.Насонова. Издательство ГЭОТАР-Медиа. 2005; 262 14. Smolen JS. Aletaha D, Keystone E. Superior efficacy of combination therapy for rheumatoid arthritis. Arthritis Rheum 2005; 52: 2975-2983. 15. Fleischman RM. Is there a need for new therapies for rheumatoid arthritis. J Rheumatol 2005; 32 SuppI. 73; 3-7. 16. Goldblatt F, Isenberg DA. New therapy for rheumatoid arthritis. Clin Exp Immunol 2005; 140: 195-204. 17. Насонов Е.Л. Применение инфликсимаба (моноклональные антитела к фактору некроза опухоли) в ревматологии: новые данные. РМЖ 2004; 20: 1123-1127 18. Goekoop-Ruiterman YPM, Vries-Bouwstra de JK, Allaart CF, et al. Clinical and Radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSy study). A randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-3390. 19. Fleischmann RM, Cohen SB, Moreland LW, et al, iRAMT study group. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. Curr Med Res Opin 2005; 21:1181 -1190 20. Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nature Immunology 3: 611-618 21. Moreland LW, Alten R, Van den Bosch F, et al. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4lg and LEA29Y eighty five days after the first infusion. Arthritis Rheum 2002; 46:1470-9. 22. Kremmer JM, Westhovens R, Leon M, et al. Treatment of rheumatoid arthritis by selective inhibition on T-Cell activatioИсточник: Насонов Е.Л. Русский медицинский журнал. 2006. Т.14. №8. С.573-577